List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 36 studies with search of: "Quintiles" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: S-1
2 Active, not recruiting S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: S-1
3 Active, not recruiting Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
Condition: Head and Neck Cancer
Intervention: Drug: temoporfin
4 Active, not recruiting S-1 and Cisplatin as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: S-1;   Drug: cisplatin
5 Recruiting A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Placebo
6 Terminated Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function
Condition: Congestive Heart Failure
Intervention: Drug: SLV320
7 Completed Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)(COMPLETED)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY);   Drug: OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY);   Drug: mometasone furoate nasal spray (MFNS) once daily;   Drug: oxymetazoline nasal spray (OXY) twice daily;   Drug: Placebo
8 Available Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Conditions: Graft vs Host Disease;   Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
9 Completed A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
Conditions: Chronic Kidney Failure;   Vascular Graft Occlusion
Intervention: Drug: PEG-hirudin
10 Completed A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
Conditions: Rheumatoid Arthritis;   and Psoriasis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention: Device: Centocor autoinjector is a prefilled, spring-powered, disposable device for the subcutaneous administration of liquid biologic drug products.
11 Recruiting Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Condition: Lung Cancer
Intervention: Device: CyPath
12 Completed A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Condition: Allergic Asthma
Interventions: Drug: AER 001;   Drug: placebo
13 Recruiting Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Drug: TAC-101;   Drug: Placebo
14 Completed Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Condition: Advanced Non-Small Cell Lung Cancer
Intervention: Drug: S-1
15 Completed STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Conditions: Neoplasms;   Diarrhea
Intervention: Drug: Sandostatin LAR Depot
16 Active, not recruiting Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Condition: Locally Advanced or Metastatic Pancreatic Cancer
Intervention: Drug: S-1
17 Completed Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-Small Cell Lung Cancer (P02064)(COMPLETED)
Conditions: Metastases of Central Nervous System;   Melanoma;   Breast Neoplasm;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Temozolomide
18 Recruiting First in Man Study With SLV341
Condition: Diabetes
Interventions: Drug: SLV341;   Drug: Placebo
19 Recruiting First Time in Human Study of Protexia
Condition: Intervention for Nerve Agent Exposure
Interventions: Biological: Protexia;   Biological: Protexia;   Biological: Protexia;   Biological: Protexia;   Biological: Protexia
20 Available Expanded Access of Prochymal® (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Condition: Graft-Versus-Host Disease
Intervention: Drug: Prochymal®

Previous Page Studies Shown (1-20) Next Page (21-36)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services